Mumps Vaccine: Perceptions and Emerging Realities

October 12, 2009 by · 7 Comments
Filed under: News, Vaccine/Disease Analysis 

Mumps outbreaks are occurring in highly vaccinated populations and this has led to differences in opinion amongst scientists around the efficacy of the vaccine, with various mechanisms of failure being put forward. It has been suggested that the number of vaccinated young adults (18-24 yrs) who contracted mumps in the US in 2006 form a small percentage of the overall vaccinated population. The fact that 84% were vaccinated with two doses is reduced to a minor detail when numbers are crunched in the “right” way. However, this is not the view of all scientists. There is concern as to why highly vaccinated populations are having mumps outbreaks. By choosing to avoid the issue, essentially ignoring the reason why young adults who have been vaccinated twice with the MMR are coming down with mumps, the evidence on the real efficacy of mass vaccination against a benign childhood disease is not discussed. Read more

Prevnar IS Safe – Have a Look at the Studies!

March 16, 2009 by · 8 Comments
Filed under: Vaccine Science 

In November of 2008, a report was published about a halted vaccine trial in India. Here is an excerpt which can be found on Livemint :

New Delhi: Patient trials of an advanced pneumonia vaccine by the domestic unit of US drug giant Wyeth Inc. have been suspended by India’s drug quality regulator after the death of an infant on whom the vaccine was tested in a trial in Bangalore.
The child had a pre-existing cardiac disorder. Indian drug rules prohibit testing on human subjects with such conditions without the prior approval of the drugs controller general of India (DCGI), the drugs quality regulator.

Indian authorities said that the trial was stopped because:

“The baby was suffering from a cardiac abnormality and should not have been included in the trial at all. It seems that the ‘inclusion-exclusion’ criteria protocol has not been adhered to by the investigator,” said Surinder Singh, drugs controller general. “We have suspended all further trials across the country.”

Read more

Merck staph vaccine enters phase II

September 21, 2008 by · 4 Comments
Filed under: General 

From Forbes:

VIENNA, Aug 28 (Reuters) – Austrian biotech firm Intercell <ICEL.VI> said on Thursday its partner Merck & Co <MRK.N> has started a Phase II clinical trial to evaluate a vaccine candidate against Staphylococcus aureus infections.

Merck is responsible for clinical development, manufacturing and marketing of the vaccine. Intercell is eligible to receive milestone payments and royalties on future net sales

This is the second trial start following a separate Phase II trial launch in December 2007. Read more

New vaccine

July 8, 2008 by · 2 Comments
Filed under: Vaccine Science 
Eleven years ago, Professor Adrian Lee, head of the School of Microbiology and Immunology at the University of New South Wales commented on the failure of the first Helicobacter vaccine to work in a European trial. The Astra Research Center in Boston, USA collaborated with the New South Wales University on the project. Professor Lee believed that two or three recombinant antigens, and a much more potent adjuvant were required. Not only did the first vaccine, which had only one antigen, not work, but the e. coli and cholera toxin adjuvants caused diarrhoea in the vaccine recipients.

Read more

Where Do They Find These Scary Statistics?


Dr. Gerberding of the CDC

[Series Links: Part II, Part III]

Remember Hannah Poling? The head of the CDC, dressed in a very nice pink suit, appeared on TV and discussed Hannah’s case. In one of her appearances she said something like this: “Vaccines prevent 33,000 deaths a year in the United States.” Just to make sure I had the statement right, I searched for the phrase and found it again, from CNN, this time in print.

Today, through immunizations given in the first two years of life, we can protect children from 16 diseases, preventing 33,000 deaths and 14 million illnesses per year.

A few searches made it clear that this is a very popular statistic. A variety of news stories included the information that vaccines prevent 33,000 deaths a year in the United States. This is an interesting number to anyone who knows a bit about the history of infectious diseases. I decided to dig deeper.

My next find was this chart, which is on a the web-site of an organization called Every Child by Two. The chart provides morbidity (incidence) and mortality (deaths) for each disease. How in the world would someone be able to calculate (for example) the exact number of cases of diphtheria which would occur and the exact number of deaths which would follow? Amazing! There must be some truly extraordinary scientific research underlying these numbers, don’t you think? Read more

Happy May 1st!

May 1, 2008 by · Comments Off on Happy May 1st!
Filed under: Uncategorized 

Insidevaccines is three months old today. In three months our team of writers, editors and proofreaders have put together 23 articles. In the days just before our opening on February 1st we also compiled 22 pages of useful information on a wide variety of vaccine related topics. We have linked to published scientific papers, to the Centers for Disease Control and to manufacturer’s product inserts.

We would like to thank all of the people who have spread links to insidevaccines across the web, with special thanks to Sandy Gottstein of Vaccination News and Ginger Taylor of Adventures in Autism for adding our link to their sites.

Disclaimer: Insidevaccines, although it is three months old, has not yet received any of the CDC recommended vaccines. Enter at your peril!

© 2010-2017 Inside Vaccines All Rights Reserved -- Copyright notice by Blog Copyright